Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An announcement from Hydration Pharmaceuticals Co. Ltd. ( (AU:HPC) ) is now available.
Hydration Pharmaceuticals has announced the lapse of 46,612,138 listed options (HPCAU), which expired unexercised on 31 December 2025 and were scheduled to convert at an exercise price of A$0.07. The expiry of this large block of options results in a simplification of the company’s capital structure, removing a potential source of future equity dilution for existing shareholders and providing greater clarity on the current issued capital base.
The most recent analyst rating on (AU:HPC) stock is a Hold with a A$0.01 price target. To see the full list of analyst forecasts on Hydration Pharmaceuticals Co. Ltd. stock, see the AU:HPC Stock Forecast page.
More about Hydration Pharmaceuticals Co. Ltd.
The Hydration Pharmaceuticals Company Limited, listed on the ASX under the code HPC, operates in the pharmaceuticals and consumer health sector, focusing on hydration-related products. The company targets retail and over-the-counter markets with formulations designed to address dehydration and related health needs.
Average Trading Volume: 4,803,902
Technical Sentiment Signal: Sell
Current Market Cap: A$2.15M
Learn more about HPC stock on TipRanks’ Stock Analysis page.